Literature DB >> 9613655

Tuberculosis in children and adolescents: California, 1985 to 1995.

M N Lobato1, K Cummings, D Will, S Royce.   

Abstract

OBJECTIVES: To describe the epidemiology and clinical characteristics of tuberculosis (TB) among children and adolescents and to define children at risk for TB.
SETTING: 4607 children 0 to 14 years of age and 1615 adolescents 15 to 19 years of age reported with TB in California.
METHODS: We analyzed surveillance data reported to the California Department of Health Services TB Control Branch from 1985 through 1995.
RESULTS: TB cases increased 22% among children 0 to 4 years of age and 66% among children 5 to 14 from 1985 through 1995. Case rates were highest among children 0 to 4 years of age (13/ 100000 children), but declined from 1993 to 1995, except for black children 0 to 4 years of age. Minority children 0 to 14 years of age had case rates 6- to 34-fold higher than did white children. Pulmonary TB was the most common site of disease in all age groups (71 to 82%). TB meningitis was most common in children 0 to 4 years of age (5%). Most children (64%) did not have cultures done; however, among culture-proved cases isoniazid-resistant Mycobacterium tuberculosis was isolated in 7%. Adolescents were more likely to have cavitary pulmonary disease (24%), to be foreign-born (78%) or homeless (4%) and to have an isoniazid-resistant strain isolated (13%) than were children 0 to 14 years of age (P < 0.05).
CONCLUSIONS: TB in children and adolescents increased substantially in the mid-1980s and early 1990s. Pediatric TB remains a serious health problem, especially among minority children and adolescents. Our findings indicate that TB control programs need improved strategies to prevent infection and detect disease in this population.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9613655     DOI: 10.1097/00006454-199805000-00012

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  7 in total

1.  The burden and outcomes of childhood tuberculosis in Cotonou, Benin.

Authors:  S Ade; A D Harries; A Trébucq; S G Hinderaker; G Ade; G Agodokpessi; D Affolabi; S Koumakpaï; S Anagonou; M Gninafon
Journal:  Public Health Action       Date:  2013-03-21

2.  Incidence and Mortality of Extrapulmonary Tuberculosis in Ukraine: Analysis of National Surveillance Data.

Authors:  Sara Khalife; Helen E Jenkins; Mariia Dolynska; Iana Terleieva; Iurii Varchenko; Tao Liu; E Jane Carter; C Robert Horsburgh; Natasha R Rybak; Vasyl Petrenko; Silvia S Chiang
Journal:  Clin Infect Dis       Date:  2022-09-10       Impact factor: 20.999

3.  Tag SNP polymorphism of CCL2 and its role in clinical tuberculosis in Han Chinese pediatric population.

Authors:  Wei-Xing Feng; Igor Mokrousov; Bin-Bin Wang; Hugh Nelson; Wei-Wei Jiao; Jing Wang; Lin Sun; Si-Rui Zhou; Jing Xiao; Yi Gu; Xi-Rong Wu; Xu Ma; Adong Shen
Journal:  PLoS One       Date:  2011-02-04       Impact factor: 3.240

4.  High caseload of childhood tuberculosis in hospitals on Java Island, Indonesia: a cross sectional study.

Authors:  Trisasi Lestari; Ari Probandari; Anna-Karin Hurtig; Adi Utarini
Journal:  BMC Public Health       Date:  2011-10-11       Impact factor: 3.295

5.  Data-driven model for the assessment of Mycobacterium tuberculosis transmission in evolving demographic structures.

Authors:  Sergio Arregui; María José Iglesias; Sofía Samper; Dessislava Marinova; Carlos Martin; Joaquín Sanz; Yamir Moreno
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-21       Impact factor: 11.205

6.  Polymorphic variation in TIRAP is not associated with susceptibility to childhood TB but may determine susceptibility to TBM in some ethnic groups.

Authors:  Shobana Rebecca Dissanayeke; Samuel Levin; Sandra Pienaar; Kathryn Wood; Brian Eley; David Beatty; Howard Henderson; Suzanne Anderson; Michael Levin
Journal:  PLoS One       Date:  2009-08-20       Impact factor: 3.240

7.  The benefits and risks of bacille Calmette-Guérin vaccination among infants at high risk for both tuberculosis and severe combined immunodeficiency: assessment by Markov model.

Authors:  Michael Clark; D William Cameron
Journal:  BMC Pediatr       Date:  2006-03-03       Impact factor: 2.125

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.